Cargando…
Mortality in schizophrenia: a measurable clinical endpoint
Over the last five years, large data sets on mortality in schizophrenia have been published which have established mortality as a measurable clinical endpoint. Four issues need clarification: whether mortality rates are declining, what the causes of death are, the effects antipsychotic treatments ha...
Autores principales: | Bushe, Chris J, Taylor, Mark, Haukka, Jari |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951589/ https://www.ncbi.nlm.nih.gov/pubmed/20923917 http://dx.doi.org/10.1177/1359786810382468 |
Ejemplares similares
-
Cancer and schizophrenia: is there a paradox?
por: Hodgson, Richard, et al.
Publicado: (2010) -
Family structure and risk factors for schizophrenia: case-sibling study
por: Haukka, Jari K, et al.
Publicado: (2004) -
Radiomic and Volumetric Measurements as Clinical Trial Endpoints—A Comprehensive Review
por: Funingana, Ionut-Gabriel, et al.
Publicado: (2022) -
Choroideremia: The Endpoint Endgame
por: Abdalla Elsayed, Maram E. A., et al.
Publicado: (2023) -
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
por: McDonald, James, et al.
Publicado: (2023)